Skip to content

Characterization of a Prospective Cohort of Women With PCOS

Metabolic and Endocrinological Characterization of a Prospective Cohort of Women With PCOS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02010814
Enrollment
500
Registered
2013-12-13
Start date
2012-01-01
Completion date
2028-01-01
Last updated
2023-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Keywords

PCOS, Inflammation, Body Composition

Brief summary

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in premenopausal women. PCOS is characterized by increase levels of testosterone, unwanted hair growth, adiposity, irregular menstrual cycle, and infertility. PCOS is associated with diabetes mellitus and cardiovascular diseases. Women with PCOS are reported to have increased levels of stress hormones, which may be associated with decreased quality of life. Increased testosterone levels in women may decrease the risk of osteoporosis. The aim of the present study is to measure levels of stress hormones in urine and describe quality of life using questionnaires. In addition we aim to characterize body composition and bone architecture using DXA and ExtremeCT. As part of the project, a Biobank with fasting blood samples from participants is established.

Interventions

None listed

Sponsors

Odense University Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* PCOS

Exclusion criteria

* pregnancy

Design outcomes

Primary

MeasureTime frameDescription
bone mass density (BMD)baselineBMD measured by DXA scans and ExtremeCT scans.

Secondary

MeasureTime frameDescription
Stress hormonesBaselineMeasurement of cortisol and steroid metabolites in 24 hour urine samples

Countries

Denmark

Contacts

Primary ContactMarianne Andersen, DMSci
marianne.andersen@rsyd.dk0045 65412502

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026